Key figures

  • No. 1 independent French pharmaceutical company
  • Present in 148 countries over 5 continents
  • Turnover of 3.9 billion euros in 2015
  • 24% of SERVIER's turnover was invested in R&D in 2015
  • Worldwide workforce of over 21 000, including nearly 3000 researchers preparing the drugs of the future
  • 92% of SERVIER's medicines are prescribed outside France
  • Servier is currently developing 23 drug candidates in oncology, cardiology, metabolic diseases, neuropsychiatry and rheumatology